Romano Brothers AND Company Trims Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Romano Brothers AND Company decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 18.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 17,154 shares of the pharmacy operator’s stock after selling 3,821 shares during the period. Romano Brothers AND Company’s holdings in Walgreens Boots Alliance were worth $160,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of WBA. Edgestream Partners L.P. acquired a new stake in Walgreens Boots Alliance in the second quarter valued at approximately $655,000. Amalgamated Bank increased its position in shares of Walgreens Boots Alliance by 13.2% in the second quarter. Amalgamated Bank now owns 217,597 shares of the pharmacy operator’s stock valued at $2,632,000 after buying an additional 25,439 shares in the last quarter. Vanguard Personalized Indexing Management LLC raised its position in shares of Walgreens Boots Alliance by 19.5% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 52,400 shares of the pharmacy operator’s stock worth $633,000 after purchasing an additional 8,538 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Walgreens Boots Alliance during the 2nd quarter valued at about $837,000. Finally, AE Wealth Management LLC grew its position in Walgreens Boots Alliance by 12.0% during the second quarter. AE Wealth Management LLC now owns 460,197 shares of the pharmacy operator’s stock valued at $5,566,000 after acquiring an additional 49,180 shares during the period. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on WBA shares. Bank of America raised their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Barclays raised their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. UBS Group increased their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Truist Financial increased their price target on shares of Walgreens Boots Alliance from $10.00 to $13.00 and gave the stock a “hold” rating in a research report on Thursday. Finally, Royal Bank of Canada increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average target price of $13.27.

Walgreens Boots Alliance Stock Down 3.2 %

WBA opened at $12.52 on Monday. The stock has a market cap of $10.81 billion, a PE ratio of -1.22, a P/E/G ratio of 1.55 and a beta of 0.64. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $23.76. The business’s fifty day simple moving average is $9.57 and its 200 day simple moving average is $9.84. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same period in the prior year, the business posted $0.66 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.52 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 7.99%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -9.77%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.